IL125098A - (3S- (3R*, 4aR*, 8aR*, 2'S*, 3'*))-2-(2'-hydroxy-3'-phenylthiomethyl (or benzyl, napthylthiomethyl, or methylnaphthyl)-4'-aza-5'-oxo-5'-(2"-methyl-3"-hydroxyphenyl) pentyl) decahydroisoquinoline-3-N-t-butylcarboxamide and its pharmaceutically acceptable salts and its prodrug analogs - Google Patents

(3S- (3R*, 4aR*, 8aR*, 2'S*, 3'*))-2-(2'-hydroxy-3'-phenylthiomethyl (or benzyl, napthylthiomethyl, or methylnaphthyl)-4'-aza-5'-oxo-5'-(2"-methyl-3"-hydroxyphenyl) pentyl) decahydroisoquinoline-3-N-t-butylcarboxamide and its pharmaceutically acceptable salts and its prodrug analogs

Info

Publication number
IL125098A
IL125098A IL12509894A IL12509894A IL125098A IL 125098 A IL125098 A IL 125098A IL 12509894 A IL12509894 A IL 12509894A IL 12509894 A IL12509894 A IL 12509894A IL 125098 A IL125098 A IL 125098A
Authority
IL
Israel
Prior art keywords
napthylthiomethyl
butylcarboxamide
decahydroisoquinoline
phenylthiomethyl
methylnaphthyl
Prior art date
Application number
IL12509894A
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/190,764 external-priority patent/US5484926A/en
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of IL125098A publication Critical patent/IL125098A/en

Links

IL12509894A 1994-02-02 1994-10-31 (3S- (3R*, 4aR*, 8aR*, 2'S*, 3'*))-2-(2'-hydroxy-3'-phenylthiomethyl (or benzyl, napthylthiomethyl, or methylnaphthyl)-4'-aza-5'-oxo-5'-(2"-methyl-3"-hydroxyphenyl) pentyl) decahydroisoquinoline-3-N-t-butylcarboxamide and its pharmaceutically acceptable salts and its prodrug analogs IL125098A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/190,764 US5484926A (en) 1993-10-07 1994-02-02 HIV protease inhibitors
IL11147294A IL111472A (en) 1994-02-02 1994-10-31 Peptidomimetic inhibitors of HIV protease and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
IL125098A true IL125098A (en) 2000-01-31

Family

ID=22702672

Family Applications (3)

Application Number Title Priority Date Filing Date
IL12509894A IL125098A (en) 1994-02-02 1994-10-31 (3S- (3R*, 4aR*, 8aR*, 2'S*, 3'*))-2-(2'-hydroxy-3'-phenylthiomethyl (or benzyl, napthylthiomethyl, or methylnaphthyl)-4'-aza-5'-oxo-5'-(2"-methyl-3"-hydroxyphenyl) pentyl) decahydroisoquinoline-3-N-t-butylcarboxamide and its pharmaceutically acceptable salts and its prodrug analogs
IL11147294A IL111472A (en) 1994-02-02 1994-10-31 Peptidomimetic inhibitors of HIV protease and pharmaceutical compositions containing them
IL12509898A IL125098A0 (en) 1994-02-02 1998-06-25 Peptidomimetic inhibitors of hiv protease and pharmaceutical compositions containing them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL11147294A IL111472A (en) 1994-02-02 1994-10-31 Peptidomimetic inhibitors of HIV protease and pharmaceutical compositions containing them
IL12509898A IL125098A0 (en) 1994-02-02 1998-06-25 Peptidomimetic inhibitors of hiv protease and pharmaceutical compositions containing them

Country Status (2)

Country Link
IL (3) IL125098A (en)
PH (1) PH31405A (en)

Also Published As

Publication number Publication date
IL111472A0 (en) 1994-12-29
IL125098A0 (en) 1999-01-26
IL111472A (en) 2000-06-01
PH31405A (en) 1998-10-29

Similar Documents

Publication Publication Date Title
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
LU91293I2 (en) Maropitant or a pharmaceutically acceptable salt of such a compound, including the citrate monohydrate salt. Cerenia
CA2251331A1 (en) Calcilytic compounds
ITMI942365A0 (en) RETINA FOR ORTHOPEDIC-TRAUMATOLOGICAL SURGERY
CA2260145A1 (en) Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
EP0711559A3 (en) Use of phosphatidylserines for the manufacture of a medicament for improving cerebration
ITBO930070A0 (en) PATIENT TABLE FOR CARRYING OUT MEDICAL TESTS.
WO1998009599A3 (en) The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
CA2179015A1 (en) Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
AU6682298A (en) Use of r-nsaid's for the prevention of alzheimer's disease
FR2720643B1 (en) Cosmetic preparation intended for the aesthetic improvement of the skin covering by elimination of corneocytes.
IT1274571B (en) PROCEDURE FOR THE PREPARATION OF ¬R- (R *, R *) | -5- (3-CHLOROPHENYL) -3- ¬2- (3,4-DIMETOXYPHENYL) -1-METHYL-ETHYL--SOXZOLIDIN-2-ONE
IL125098A (en) (3S- (3R*, 4aR*, 8aR*, 2'S*, 3'*))-2-(2'-hydroxy-3'-phenylthiomethyl (or benzyl, napthylthiomethyl, or methylnaphthyl)-4'-aza-5'-oxo-5'-(2"-methyl-3"-hydroxyphenyl) pentyl) decahydroisoquinoline-3-N-t-butylcarboxamide and its pharmaceutically acceptable salts and its prodrug analogs
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
HU912594D0 (en) Solid, orally usable forms containing iphosphamide as active agents
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
CA2042936A1 (en) Treatment of ocular hypertension with a synergistic combination for ophthalmic use
CA2260863A1 (en) Treatment of psychotic disorders
IT8922246A0 (en) PROCEDURE FOR THE PREPARATION OF 3-CYANO-3,5,5'-TRIMETHYL-1-CYCLOHEXANONE
CA2353808A1 (en) Agent for lowering endothelin levels
WO1986006960A3 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
CA2135752A1 (en) Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
CA2340920A1 (en) A method for preventing the onset of asthma
FR2701846B1 (en) Use of trimetazidine for obtaining medicaments intended for the treatment of disorders linked to the therapeutic use of immunosuppressants.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
FF Patent granted
KB Patent renewed
EXP Patent expired